New York Southern Bankruptcy Court

Case number: 1:18-bk-12429 - Aralez Pharmaceuticals Trading Designated Activity - New York Southern Bankruptcy Court

Case Information
Case title
Aralez Pharmaceuticals Trading Designated Activity
Chapter
11
Judge
Martin Glenn
Filed
08/10/2018
Last Filing
06/28/2019
Asset
Yes
Vol
v
Docket Header

MEGA, JtAdm




U.S. Bankruptcy Court
Southern District of New York (Manhattan)
Bankruptcy Petition #: 18-12429-mg

Assigned to: Judge Martin Glenn
Chapter 11
Voluntary
Asset


Date filed:  08/10/2018

Debtor

Aralez Pharmaceuticals Trading Designated Activity Company

2 Hume Street
Fourth Floor
Dublin 2 D02 FT82
OUTSIDE U. S.
Ireland
Tax ID / EIN: XX-XXXXXXX
fka
Pozen Limited

fka
Aralez Pharmaceuticals Trading Limited


represented by
Paul V. Shalhoub

Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
(212) 728-8764
Fax : (212) 728-8111
Email: [email protected]

Robin Spigel

Willkie Far & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
212 728-8822
Fax : 212 728-8111
Email: [email protected]

U.S. Trustee

United States Trustee

Office of the United States Trustee
U.S. Federal Office Building
201 Varick Street, Room 1006
New York, NY 10014
(212) 510-0500
 
 

Latest Dockets
Date Filed#Docket Text
08/14/2018Docket Text
An order has been entered in this case directing the procedural consolidation and joint administration of the chapter 11 cases of Aralez Pharmaceuticals US Inc. and its affiliates that have concurrently commenced chapter 11 cases. The docket in the chapter 11 case of Aralez Pharmaceuticals US Inc., Case No. 18-12425 (MG), should be consulted for all matters affecting this case.
(Gomez, Jessica). (Entered: 08/14/2018)
08/14/20185Docket Text
Order signed on 8/14/2018 Granting Motion Directing Joint Administration of Related Chapter 11 Cases Under The Lead Case of Aralez Pharmaceuticals US Inc., Case No. 18-12425(MG) (Related Doc # 2). (Gomez, Jessica) (Entered: 08/14/2018)
08/10/2018Docket Text
Judge Martin Glenn added to the case. (Porter, Minnie). (Entered: 08/10/2018)
08/10/20184Docket Text
Declaration of Michael Kaseta in Support of Chapter 11 Petitions and First Day Pleadings filed by Robin Spigel on behalf of Aralez Pharmaceuticals Trading Designated Activity Company. (Spigel, Robin) (Entered: 08/10/2018)
08/10/20183Docket Text
Motion to Extend Deadline to File Schedules or Provide Required Information / Debtors' Motion for Order Extending Deadline for Debtors to File their Schedules of Assets and Liabilities and Statements of Financial Affairs filed by Robin Spigel on behalf of Aralez Pharmaceuticals Trading Designated Activity Company. (Spigel, Robin) (Entered: 08/10/2018)
08/10/20182Docket Text
Motion for Joint Administration / Debtors' Motion for Order Authorizing Joint Administration Pursuant to Rule 1015(b) of the Federal Rules of Bankruptcy Procedure filed by Robin Spigel on behalf of Aralez Pharmaceuticals Trading Designated Activity Company. (Spigel, Robin) (Entered: 08/10/2018)
08/10/2018Docket Text
Receipt of Voluntary Petition (Chapter 11)(18-12429) [misc,824] (1717.00) Filing Fee. Receipt number 12714853. Fee amount 1717.00. (Re: Doc # 1) (U.S. Treasury) (Entered: 08/10/2018)
08/10/20181Docket Text
Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Filed by Paul V. Shalhoub of Willkie Farr & Gallagher LLP on behalf of Aralez Pharmaceuticals Trading Designated Activity Company. (Shalhoub, Paul) (Entered: 08/10/2018)